GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

galcanezumab   Click here for help

GtoPdb Ligand ID: 8967

Synonyms: clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
Approved drug Immunopharmacology Ligand
galcanezumab is an approved drug (FDA (2018))
Compound class: Antibody
Comment: Galcanezumab (LY2951742) is a monoclonal antibody targeting calcitonin A and B (CALCA a.k.a. α-CGRP and CALCB a.k.a. β-CGRP respectively), whose anti-migraine and analgesic actions can be applied clinically.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent WO2007076336 [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)  |  US FDA (2018)
International Nonproprietary Names Click here for help
INN number INN
10277 galcanezumab
Synonyms Click here for help
clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 609
Other databases
GtoPdb PubChem SID 310264747
Search PubMed clinical trials galcanezumab
Search PubMed titles galcanezumab
Search PubMed titles/abstracts galcanezumab